Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Sumit K. Chanda, Shuofeng Yuan et al.|Nature|2020Cited by 856
SARS-CoV-2 spike E484K mutation reduces antibody neutralisationSonia Jangra, Michael Schotsaert, Giulio Kleiner et al.|The Lancet Microbe|2021Cited by 435
A Large-scale Drug Repositioning Survey for SARS-CoV-2 AntiviralsLaura Riva, Sumit K. Chanda, Shuofeng Yuan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 113
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein GeneYíngyún Caì, Luis Martínez‐Sobrido, Chengjin Ye et al.|mBio|2020Cited by 48
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Michael Schotsaert, Sonia Jangra et al.|Nature Communications|2022Cited by 41